The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Influence of PET/CT on therapeutic management after resection of high-risk or very high-risk GIST.
J. Bertz-Lepel
No relevant relationships to disclose
J. Rahm
No relevant relationships to disclose
D. Pink
No relevant relationships to disclose
D. Schoeler
No relevant relationships to disclose
P. Reichardt
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis